Funded Awards January 2019

Funded Awards
PI Agency Title
Jeffrey Bednarski NIH/U54/Regents of University of California – San Francisco Primary Immune Deficiency Treatment Consortium
Francis Cole People-Center Research Foundation/PCRF/Children’s Hospital of Philadelphia PEDSnet – A Pediatric Learning Health System
Eve Colson NIH/R01/Boston University Improving Care Giver Adherence to Recommended Infant C…
Vikas Dharnidharka NIH/U01/Children’s Mercy Kansas City Chronic Kidney Disease in Children (CKID IV)
Patricia Dickson NIH/R33/LA BioMed Modified Neural Stem Cells for Glycosylation-Independe…
Allan Doctor Washington University OVCR Application of Community Based Group Model Building to…
Audrey Odom John NIH/R21 Towards noninvasive diagnosis of malaria
Jessica Pittman Cystic Fibrosis Foundation Therapeutics, Inc. Washington University in St. Louis ARC Application
Gregory Storch HRSA/City of St. Louis HIV Prevention Intervention for Targeted Populations a…
Gregory Storch HRSA/St. Clair County DOH Perinatal Case Management
Michael Thompson WU DRC/Pilot and Feasibility Targeting Bile Acid Homeostasis in Offspring Exposed T…
Funded Awards
Funded Grants September 2021

PI Agency Title Megan Cooper NIH/ UG3/UH3/Baylor College of Medicine Safety and Efficacy of Itacitinib in treatment of JAK/STAT gain of function disorders Amjad Horani CDI Mechanisms of Primary Ciliary Dyskinesia Cynthia Ortinau Brain & Behavior Research Foundation Association of Parental Psychological Distress with Brain and Neurodevelopment in Congenital Heart …

Funded Awards
Funded Grants August 2021

PI Agency Title Fahd Ahmad NIH/CCHMC EMS for Children: Pediatric Emergency Care Applied Research Network (PECARN)  Jonathan Cooper NIH/R56 Characterizing and testing the efficacy of AAV-mediated gene therapy in a novel CRISPR/Cas9 generated sheepmodel of Cln1 disease. Jorge Di Paola NIH/R01/Ohio State University A Reversible Aptamer Based Therapeutic to Treat …

Funded Awards
Funded Grants July 2021

PI Agency Title Mohamed Abdelbaki EIF/The Hospital for Sick Children 3CI Study: Childhood Cancer Combination Immunotherapy. Phase 1b and Expansion Study of Nivolumab Combination Immunotherapy in Children, Adolescent and Young Adult (CAYA) Patients with Relapsed/Refractory Hypermutant Cancers Amy Armstrong Aflac Foundation/Children’s Healthcare of Atlanta A Maintenance Protocol of Sirolimus in …